Senior Medical Science Liaison, Pediatric Rare Diseases (Western Region)

About Us

Founded in 2011, Fulgent has evolved into a premier, full-service genomic testing company built around a foundational technology platform.

Through our diverse testing menu, Fulgent is focused on transforming patient care in oncology, anatomic pathology, infectious and rare diseases, and reproductive health. We believe that by providing a wide range of effective, flexible testing options in conjunction with best-in-class service and support, we can redefine the way medicine is managed for patients and clinicians alike.

Since integrating with our therapeutic development business, Fulgent is also developing drug candidates for treating a broad range of cancers using a novel nanoencapsulation and targeted therapy platform. By merging our fields of expertise, we aim to become a fully integrated precision medicine company.

Summary of Position

The Senior Medical Science Liaison (Sr. MSL), Pediatric Rare Diseases, is an experienced, board-certified genetic counselor with deep expertise in pediatric and rare disease genetics who serves as an advanced scientific and strategic resource for our commercial, clinical education, and medical affairs teams. This role operates with a high degree of autonomy, leading complex scientific engagements with key opinion leaders (KOLs), shaping regional and national medical affairs strategy, and mentoring junior MSLs and genetic counselors. The Sr. MSL ensures high-quality education and strategic communication regarding Fulgent's pediatric rare disease genetic testing portfolio, including whole genome sequencing solutions such as FulGenome. The ideal candidate brings a proven track record of scientific leadership, a dynamic personality with a strong background in clinical and molecular genetics, is passionate about translating complex science into actionable insights, and thrives in a fast-paced, collaborative environment.

Key Job Elements

• Serve as a subject matter expert on pediatric rare disease genetic testing, including whole exome sequencing, whole genome sequencing (FulGenome), TruPath™ Genome long-read analysis, next-generation sequencing (NGS) panels, and exome-based rare disease diagnostic testing.
• Support and educate genetic counselors, medical geneticists, pediatric neurologists, developmental pediatricians, NICU decision makers, and related providers at Children's Hospitals and academic medical centers on the clinical utility and scientific foundation of Fulgent products and services.
• Collaborate closely with the Genomics Sales team, marketing, medical affairs, and Clinical Development/R&D teams to support field-based efforts targeting Children's Hospitals and academic institutions with clinical credibility and strategic insights.
• Conduct scientific presentations, roundtable discussions, and one-on-one meetings to deliver product training and clinical updates on pediatric rare disease testing, including FulGenome whole genome analysis and TruPath™ Genome long-read insights.
• Serve as the lead clinical liaison to key regional and national opinion leaders in pediatric genetics and rare disease, developing and executing KOL engagement strategy and fostering long-term, independent professional relationships.
• Attend and represent Fulgent Genetics at regional and national pediatric genetics and rare disease conferences, symposia, and events.
• Provide timely, high-level feedback and field insights to help shape medical, research, and commercial strategy at the regional and national level.
• Mentor, coach, and help onboard junior MSLs and field-based genetic counselors, sharing best practices and serving as a scientific resource within the broader Medical Affairs team.
• Contribute to Medical Affairs research strategy, including support for investigator-initiated trials, real-world evidence generation, and abstract/publication development in partnership with Clinical Development.
• Participate in and help lead scientific advisory boards, providing strategic input on pediatric rare disease testing initiatives.
• Ensure compliant and ethical interactions with external healthcare professionals.
• Maintain deep technical fluency in Fulgent's FulGenome whole genome analysis—covering SNVs, CNVs, genome-wide deletions and duplications, mitochondrial variants, and repeat expansions across 20,000+ genes in a single report—as well as TruPath™ Genome, which adds long-range insights for complex structural variants, repeat expansions, difficult-to-map regions, and phasing without parental samples.